Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic stem cell therapy in relapsed/refractory B cell lymphomas Meeting Abstract


Authors: Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; Palomba, M. L.; Giralt, S. A.; Perales, M. A.
Abstract Title: Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic stem cell therapy in relapsed/refractory B cell lymphomas
Meeting Title: 2019 TCT Meetings of ASBMT and CIBMTR
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 25
Issue: 3 Suppl.
Meeting Dates: 2019 Feb 20-24
Meeting Location: Houston, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2019-02-01
Start Page: S183
End Page: S184
Language: English
ACCESSION: WOS:000540655500262
PROVIDER: wos
DOI: 10.1016/j.bbmt.2018.12.329
Notes: Meeting Abstract: 254 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
  2. Sergio Andres Giralt
    1050 Giralt
  3. Craig Steven Sauter
    334 Sauter
  4. Miguel-Angel Perales
    913 Perales
  5. Molly Anna Maloy
    269 Maloy
  6. Parastoo Bahrami Dahi
    294 Dahi
  7. Michael Scordo
    365 Scordo
  8. Connie Wing-Ching Lee Batlevi
    176 Batlevi
  9. Gunjan Lalitchandra Shah
    418 Shah
  10. Tania Jain
    27 Jain
  11. Jason Earl Chan
    28 Chan
  12. Yakup Batlevi
    10 Batlevi
Related MSK Work